HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics
$60.75M funding round led by ARCH Venture Partners with 6 Dimensions Capital HiberCell will build on pioneering tumor dormancy research conducted by the Julio Aguirre-Ghiso Lab at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai HiberCell, a …
Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases
New York, NY (January 15, 2019) – The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company Paradigm Biopharmaceuticals Ltd. (ASX: PAR) …
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
New York, NY (December 04, 2018) — Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors …
RenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease
Mount Sinai Health System announced today that RenalytixAI PLC, a Mount Sinai exclusive licensee and development collaborator, had completed a public listing that valued the company at $85 million on the London Stock Exchange’s Alternative Investment Market. The public listing raised $29 …
Mount Sinai and AllerGenis, LLC Announce Partnership to Bring Novel, Precision Diagnostics to Food Allergy Patients
New Diagnostic Technology Will Provide Information to Both Patients and Clinicians More than 30 million people in the United States and Europe have food allergies, according to the National Institute of Allergy and Infectious Diseases, National Institutes of Health. AllerGenis’ food allergy …
MSIP Recognizes Innovators at 2018 SINAInnovations Awards Ceremony
Mount Sinai Innovation Partners (MSIP) presented the Inventor of the Year award to Anne Schaefer, MD, PhD, and the Deal of the Year award to Julio A. Aguirre-Ghiso, PhD, at the 2018 SinaInnovations awards ceremony. The awards recognize exceptional Mount Sinai innovators …
RxHealth™ Raises $1.8 Million Seed Round, Launches Bulk Prescription™ to Population Health Programs
Digital medicine platform Rx.Health, a Mount Sinai Health System spinoff and provider of RxUniverse™, recently announced that it has raised $1.8 million in seed funding. The funding will be used to diversify Rx.Health’s client base and support its first-to-market Bulk Prescription™ digital …
Mount Sinai and Novotalk sign a joint venture agreement to bring innovative speech and language therapeutic technologies to patients
On-demand (virtual) health solutions enable the patient to undergo a therapeutic process with a computer acting as a virtual clinician • The licensed clinicians supervise the process, leveraging mass data collection for clinical insights not otherwise available in a regular clinical setting …
Erik Lium, PhD, Promoted to Executive Vice President of Mount Sinai Innovation Partners
The Mount Sinai Health System has announced Erik Lium, PhD, has been promoted to Executive Vice President of Mount Sinai Innovation Partners (MSIP). His new, expanded role will include broad responsibilities for innovation, commercialization, and entrepreneurship across the Mount Sinai Health System …
The Pioneers of Kidney Disease Prevention: Meet Mount Sinai Nephrologists Steven Coca and Girish Nadkarni
As colleagues in Mount Sinai’s Division of Nephrology, Steven Coca, DO, MS and Girish Nadkarni, MD, MPH share a mutual passion for revolutionizing chronic kidney disease management on a global scale. Drs. Coca and Nadkarni are the co-inventors of KidneyTrackTM, an artificial …